Antiserum, Hai, Mumps Virus
The Antiserum, HAI, Mumps Virus is a hemagglutination inhibition antiserum used in laboratory testing to identify and serotype the mumps virus. It is an FDA Class 1 device subject to general controls only, representing the lowest risk category with no premarket notification requirement. The product code is GRD, regulated under 21 CFR 866.3380 in the Microbiology specialty. No special flags apply to this device.
Research product code GRD in seconds
The Research Assistant summarizes clearances, adverse event trends and regulation context for a product code — and cites every record.
Free to try · every answer cites its records
Basic Information
- Product Code
- GRD
- Device Class
- FDA class 1
- Regulation Number
- 866.3380
- Medical Specialty
- Microbiology
- Review Panel
- MI
- Submission Type
- 4
Device Characteristics
510(k) Clearance History
Related 510(k) Clearances
This FDA classification is associated with 1 510(k) clearance via K numbers.
| K Number | Device Name | Decision Date | Decision | Applicant |
|---|---|---|---|---|
| K833077 | WELLCOGEN H. INFLUENZAL ZL21 | Jan 10, 1984 | Substantially Equivalent | Wellcome Diagnostics |
FEI Numbers
This FDA classification entry is associated with 1 FEI number. Click on an entry to view related FDA registrations.
Registration Numbers
This FDA classification entry is associated with 1 registration number. Click on an entry to view related FDA registrations.